Placebo for Rimegepant 75 mg, VYDURA 75 mg oral lyophilisate clinical trials

C4951012 - BHV3000-407: A Phase 4, Randomized, Double-blind, Placebo controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults with a History of Inadequate Response to Oral Preventive Medications

This study is testing a new medicine, Rimegepant (also known as VYDURA), to see if it can help prevent migraine headaches. It's for adults who've tried other migraine prevention medicines without much success. Researchers want to know if it reduces how often migraines happen.